News

20.10.25 Medannex Unveils Positive Clinical Data on MDX-124 at ESMO 2025
02.10.25 Medannex’s First-in-Class Therapeutic Granted FDA Orphan Drug Designation for Biliary Tract Cancer
21.03.25 Medannex unveils novel approach to osteosarcoma treatment at ESMO Meeting
25.07.24 Medannex awarded ‘Transforming Cancer Therapeutics’ grant to accelerate new treatment for bone cancer in children
01.06.24 Medannex unveils First-in-Human study of novel cancer therapy at ASCO 2024
18.03.24 Medannex Strengthens Global Intellectual Property Portfolio for Novel Clinical Asset
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7